Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials
用户EO9nReo4Hj6s
19天前
64
10
已完结
1. 系统已在2025-05-02 17:40:34对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41571-025-01011-3
文献链接: https://www.nature.com/articles/s41571-025-01011-3
其他信息:
出版社: Springer Science and Business Media LLC
作者: Sophie M. Ernst; Mihaela Aldea; Jan H. von der Thüsen; Adrianus J. de Langen; Egbert F. Smit; Marthe S. Paats; Joachim G. J. V. Aerts; Laura Mezquita; Sanjay Popat; Benjamin Besse; Jordi Remon; Christian Rolfo; Hendrikus J. Dubbink; Anne-Marie C. Dingemans
全文下载地址: https://www.nature.com/articles/s41571-025-01011-3.pdf
